CRISPR Therapeutics AG

Scientist II, CRISPR-X - Gene Insertion

CRISPR Therapeutics AG$130K — $140K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • 5-7 years of experience in gene editing technologies and application development.
  • In-depth knowledge of CAR T cell engineering and functional characterization of CAR-T cells.
  • PhD in a related field or significant relevant experience ranging from 10 to 12 years without a PhD.
  • Strong problem-solving capabilities and a creative mindset.
  • Exceptional writing and communication skills.
  • Demonstrated continuous self-improvement in scientific skills.
  • Capacity to work collaboratively within a research team.

Responsibilities

  • Lead the design and optimization of next-gen gene editing research, focusing on gene insertions.
  • Conduct molecular biology experiments, including cloning and various DNA/RNA analyses.
  • Leverage immune cell biology knowledge for construct design and target selection.
  • Research and develop innovative solutions from published literature for gene editing challenges.
  • Create translational assays to assess gene editing in varied biological contexts.

Benefits

  • Opportunity to work with a pioneering team in gene editing at CRISPR Therapeutics.
  • On-site collaborative work environment with a diverse team.
  • Engagement in cutting-edge research with real-world implications for human diseases.
  • Potential for professional growth and advancement within a leading biotech company.
  • Encouragement of continuous learning and self-improvement.
Full Job Description

Job Description:

Position Summary

Are you passionate about developing next-gen CRISPR therapies? We are seeking a highly motivated and creative Scientist II to grow our diverse, innovation-focused CRISPR-X team that pioneers novel gene editing therapies for human disease. We are part of CRISPR Therapeutics, a leading gene editing company with a broad clinical portfolio. The successful candidate will be an integral part of our team, whose aim is to research, develop and advance the next generation of genome editing modalities and genetic therapies for a wide range of human indications. The position requires enthusiasm, passion, outstanding skills in the art, attention to detail, and a desire to create new medicines for patients

Responsibilities

  • Lead, design, and optimize research with the aims of exploring and developing next-generation gene editing strategies, primarily gene insertions, using CRISPR-based tools and beyond, and synthetic immunology.
  • Design, execute, and interpret research requiring molecular biology techniques including cloning, qPCR/ddPCR, NGS, RNA and DNA analysis, cell culture, and other cell-based assays.
  • Use knowledge of immune cell biology to guide construct design, target selection, and interpretation of phenotypic outcomes of in-vivo CAR T and other immune studies.
  • Dissect published literature to find novel solutions to gene editing and immunology problems.
  • Develop a deep understanding of the biology underlying new disease indications and design translational assays and experimental strategies to enable evaluation of gene editing and CAR approaches across in vitro and in vivo systems.

Minimum Qualifications

  • Prior experience with gene editing, including experience applying and developing next generation gene editing technologies, such as recombinases, retrotransposons or other integration approaches, in an academic and/or industry setting, with a track record demonstrating significant contributions.
  • Hands-on experience with chimeric antigen receptor (CAR) T cell engineering, including CAR construct design, gene editing and/or transgene delivery in primary human T cells, and functional characterization of the resulting CAR-T cells.
  • Ph.D. in biology, bioengineering, immunology, or related discipline with 2-5+ years of professional experience, or non-PhD and 10-12+ years of progressive, relevant experience.
  • Outstanding problem-solving skills and attitude to think outside the box.
  • Excellent writing, reviewing, and presentation skills.
  • Challenges oneself continuously to enhance scientific capabilities.
  • Ability to work independently as well as collaboratively in a results-oriented research team environment.
  • Must possess critical thinking and self-reliance to solve tasks independently.
  • Self-motivated and scientifically rigorous, with outstanding organization and multitasking capability.
  • Entrepreneurial spirit showing resourcefulness, accountability, agility to pivot, transparency, and productivity.

Preferred Qualifications

  • Prior experience with protein and/or RNA engineering.
  • Prior experience establishing next-generation CAR T cells ex-vivo and/or in-vivo CAR T cells.
  • Prior experience with diverse delivery technologies, including transfection/nucleofection, lipid nanoparticles, and viral vectors/particles.
  • Prior experience designing and executing in vivo studies, including downstream tissue processing.
  • Experience managing and mentoring junior scientists.

Competencies

  • Collaborative – Openness, One Team

  • Undaunted – Fearless, Can-do attitude

  • Results Orientation – Delivering progress toward our mission. Sense of urgency in solving problems.

  • Entrepreneurial Spirit – Proactive. Ownership mindset.

​Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.  

Scientist II: Base pay range of $130,000 to $140,000+ bonus, equity and benefits

The range provided is CRISPR Therapeutics’ reasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities.

About CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company develops its products through in-house research programs and partnerships with biopharmaceutical companies and academic researchers. Its lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. The company was formerly known as Inception Genomics AG and changed its name to CRISPR Therapeutics AG in April 2014. CRISPR Therapeutics AG was founded in 2013 and is headquartered in Zug, Switzerland.
Learn more about CRISPR Therapeutics AG
Size
473 employees
Market Cap
$3.3 billion
Industry
Net Income
-$348.8 million
Founded
2013
5 Year Trend
+181.6%
Revenue
$720,000
NASDAQ

Similar Jobs

More Jobs at CRISPR Therapeutics AG

More Pharmaceuticals & Biotech Jobs

Find similar Scientist II, CRISPR-X - Gene Insertion jobs: